Intrathecal Morphine on Transcranial Electric Motor-Evoked Potentials
EIM
Effects of Intrathecal Morphine on Transcranial Electric Motor-Evoked Potentials in Patients Undergoing Posterior Spine Fusion
1 other identifier
observational
36
1 country
1
Brief Summary
Patients undergoing posterior spinal fusion (PSF) procedures for scoliosis are at risk for iatrogenic neurologic injury of the spinal cord and/or spinal nerve roots during surgical correction of the abnormal spinal curvature. The degree of neurologic injury can range from minor sensory deficits to complete paraplegia. Surgeons at CHOP utilize neurophysiologists to identify impending neurologic injury. These consultants monitor spinal cord pathways by recording and analyzing evoked potentials during the operation. Evoked potentials are low voltage electrical signals generated in response to transcranial or transcutaneous electrical stimulation of motor and sensory neural pathways. Some patients undergoing PSF receive an injection of morphine into the cerebrospinal fluid during the operation. This intrathecal (IT) morphine has potent analgesic effects. While most commonly used anesthetic agents have well-characterized effects on evoked potentials, little data exists on the effects of IT morphine on transcranial electric motor-evoked potentials (TceMEPs). This is a prospective observational study to characterize the effects of IT morphine on TceMEPs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 9, 2008
CompletedFirst Posted
Study publicly available on registry
January 17, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedSeptember 16, 2009
September 1, 2009
1.7 years
January 9, 2008
September 14, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To quantitatively evaluate the effects of IT morphine on TceMEP amplitude and latency in patients undergoing PSF who have IT morphine injected after instrumentation
30 minute period - Group 1 - after IT morphine injection or during skin closure for Group 2.
Study Arms (2)
1
Group 1 will be subjects who receive Intrathecal Morphine.
2
Group 2 will be subjects who do not receive Intrathecal Morphine.
Interventions
* In the IT morphine group, prior to IT morphine injection (within 15 minutes of the injection), the neurophysiologist will be asked to obtain a set of TceMEP recordings. The recordings collected at this time will be labeled "Baseline." These will serve as controls for subsequent recording comparisons. * In the IT morphine group, the time of IT morphine injection will be recorded, as well as the dose. A timer will be started. The neurophysiologist will then be asked to collect four additional sets of TceMEP recordings, at 5, 10, 20, and 30 minutes after morphine injection.
Eligibility Criteria
Children ages 11-18 with idiopathic scoliosis who are scheduled to have a posterior spinal fusion.
You may qualify if:
- Intrathecal Morphine Group:
- All patients with idiopathic scoliosis aged 11 through and including 18 who present to CHOP for posterior spinal fusion will be eligible
- Patients with procedures anticipated to extend to or below the second lumbar vertebral level
- Only patients given intrathecal morphine after curve correction and instrumentation will be studied
- Control Group:
- All patients with idiopathic scoliosis aged 11 through and including 18 who present to CHOP for posterior spinal fusion will be eligible
- Patients with procedures not anticipated to extend to or below the second lumbar vertebral level
- Patients who do not receive IT morphine injection as part of their routine anesthetic care
You may not qualify if:
- Intrathecal Morphine Group:
- Patients who receive inhaled anesthetic agents before or during the 30 minutes following IT morphine injection
- Patients who receive neuromuscular blocking drugs within an hour before or during the 30 minutes following IT morphine injection.
- Patients who develop significant changes in TceMEPs prior to intrathecal morphine injection
- Patients with intraoperative hemodynamic instability which requires continuous vasoactive drug infusion (e.g., dopamine)
- Patients with neuromuscular, congenital, or other non-idiopathic scoliosis
- Pregnant or lactating females
- Control Group:
- Patients who receive inhaled anesthetic agents before or during the 30 minutes following IT morphine injection
- Patients who receive neuromuscular blocking drugs within an hour before or during the 30 minutes following IT morphine injection.
- Patients who develop significant changes in TceMEPs prior to the study interval
- Patients with intraoperative hemodynamic instability which requires continuous vasoactive drug infusion (e.g., dopamine)
- Patients with neuromuscular, congenital, or other non-idiopathic scoliosis
- Pregnant or lactating females
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Children's Hospital of Philadephia
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Stricker, MD
Children's Anesthesiology Associates, Ltd.
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 9, 2008
First Posted
January 17, 2008
Study Start
August 1, 2007
Primary Completion
April 1, 2009
Study Completion
April 1, 2009
Last Updated
September 16, 2009
Record last verified: 2009-09